-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-3706674 in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-3706674 in Gastric Cancer Drug Details: BI-3706674 is under development for the treatment of KRAS...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-3706674 in Esophageal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-3706674 in Esophageal Cancer Drug Details: BI-3706674 is under development for the treatment of KRAS...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-3706674 in Adenocarcinoma Of The Gastroesophageal Junction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-3706674 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: BI-3706674 is under development for the...
-
Product Insights
![]()
Net Present Value Model: Comtan/Stalevo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Comtan/Stalevo Drug Details Carbidopa, Entacapone, Levodopa...
-
Company Profile
![]()
Employers Holdings Inc – Company Profile
Employers Holdings Inc (EHI) is an insurance holding company. The company offers workers’ compensation insurance products and services primarily catering to small businesses involved in low-to-medium hazard industries. It provides various services such as claims management, fraud prevention, loss control, premium audit, managed care services, online customer support services, insurance advisory services, return to work programs, and safety promotion programs. It distributes its products through independent national, regional, and local agents and strategic partners such as ADP, Inc. (ADP) across...
Add to Basket -
Analyst Opinions
![]()
Governance, Risk and Compliance – The Kenyan Insurance Industry
GlobalData’s "Governance, Risk and Compliance - The Kenyan Insurance Industry", report is the result of extensive research into the insurance regulatory framework in Kenya. It provides detailed analysis of the insurance regulations for life, property, motor, liability, personal accident and health, and marine, aviation and transit insurance. The report specifies various requirements for the establishment and operation of insurance and reinsurance companies and intermediaries. The report brings together GlobalData’s research, modeling and analysis expertise, giving insurers access to information on...
-
Government & Regulation
![]()
Uganda Upstream Fiscal and Regulatory Report – 2nd Bid Round Planned for 2019
Uganda offers PSAs for investment in its upstream oil and gas sector. Following the passage of the National Oil and Gas Policy in 2008, the country has progressed its fiscal and regulatory regime with the adoption of the PEDP Act in 2013 and the supplemental PEDP Regulations in 2016. The new legislation has improved the regulatory climate. Following the regulatory overhaul and first licensing round, launched in 2015, three PSAs were signed in in late 2017. A second licensing round...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.